Ras Activity Levels Control the Development of Pancreatic Diseases

Gastroenterology

Volumn 137, Issue 3, 2009, Pages

  Ji, Baoan ^a   Tsou, Lilian ^a   Wang, Huamin ^a   Gaiser, Sebastian ^a   Chang, David Z ^a   Daniluk, Jaroslaw ^a   Bi, Yan ^b   Grote, Tobias ^a   Longnecker, Daniel S ^c   Logsdon, Craig D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN P53; RAS PROTEIN;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC PAPILLARY CARCINOMA; HEPATOBILIARY SYSTEM; METASTASIS; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC DUCTAL ADENOCARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION;

EID: 69249148349     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.05.052     Document Type: Article

References (35)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Hingorani S.R., Petricoin E.F., Maitra A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4 (2003) 437-450
3. Grippo P.J., Nowlin P.S., Demeure M.J., et al. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 63 (2003) 2016-2019
4. Guerra C., Schuhmacher A.J., Canamero M., et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11 (2007) 291-302
5. Hruban R.H., Adsay N.V., Bores-Saavedra J., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25 (2001) 579-586
6. Sarkisian C.J., Keister B.A., Stairs D.B., et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9 (2007) 493-505
7. Aguirre A.J., Bardeesy N., Sinha M., et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17 (2003) 3112-3126
8. Jackson E.L., Willis N., Mercer K., et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15 (2001) 3243-3248
9. Jonkers J., Meuwissen R., van der Gulden H., et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29 (2001) 418-425
10. Ji B., Bi Y., Simeone D., et al. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121 (2001) 1380-1390
11. Ji B., Song J., Tsou L., et al. Robust acinar cell transgene expression of CreErT via BAC recombineering. Genesis 46 (2008) 390-395
12. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
13. Apte M.V., Haber P.S., Applegate T.L., et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43 (1998) 128-133
14. Qian Y., Zhang J., Yan B., et al. DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J Biol Chem 283 (2008) 2896-2905
15. Coppe J.P., Patil C.K., Rodier F., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6 (2008) 2853-2868
16. Habbe N., Shi G., Meguid R.A., et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A 105 (2008) 18913-18918
17. De La O.J.P., Emerson L.L., Goodman J.L., et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 105 (2008) 18907-18912
18. Siveke J.T., Einwachter H., Sipos B., et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 12 (2007) 266-279
19. Murtaugh L.C., Stanger B.Z., Kwan K.M., et al. Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci U S A 100 (2003) 14920-14925
20. Carriere C., Young A.L., Gunn J.R., et al. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun 382 (2009) 561-565
21. Duan R.D., Zheng C.F., Guan K.L., et al. Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. Am J Physiol 268 (1995) G1060-G1065
22. Ferbeyre G. Barriers to Ras transformation. Nat Cell Biol 9 (2007) 483-485
23. Greten F.R., Wagner M., Weber C.K., et al. TGF alpha transgenic mice. A model of pancreatic cancer development. Pancreatology 1 (2001) 363-368
24. Hingorani S.R., Wang L., Multani A.S., et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7 (2005) 469-483
25. Bardeesy N., Aguirre A.J., Chu G.C., et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A 103 (2006) 5947-5952
26. Kopnin P.B., Agapova L.S., Kopnin B.P., et al. Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res 67 (2007) 4671-4678
27. Almoguera C., Shibata D., Forrester K., et al. Most human carcinomas of the exocrine pancreas contain mutant c- K-ras genes. Cell 53 (1988) 549-554
28. Hruban R.H., van Mansfeld A.D., Offerhaus G.J., et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant- enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143 (1993) 545-554
29. Luttges J., Diederichs A., Menke M.A., et al. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer 88 (2000) 2495-2504
30. Lohr M., Kloppel G., Maisonneuve P., et al. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 7 (2005) 17-23
31. Tada M., Ohashi M., Shiratori Y., et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110 (1996) 227-231
32. Muller-Decker K., Furstenberger G., Annan N., et al. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Gastroenterology 130 (2006) 2165-2178
33. Wagner M., Greten F.R., Weber C.K., et al. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 15 (2001) 286-293
34. Hruban R.H., Adsay N.V., Albores-Saavedra J., et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66 (2006) 95-106
35. Hruban R.H., Maitra A., Kern S.E., et al. Precursors to pancreatic cancer. Gastroenterol Clin North Am 36 (2007) 831-849 vi